Purchase Order 75N93020P01274
Award Date 9/2/20
Potential Completion Date 10/3/20
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Illumina, Inc. on July 29, 2020, for HiSeq 3000/4000SBS kit (300 cycles) and MiSeq reagent kit V2 (300 cycle) with a ceiling value of $13,569.20.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed price and ultimate completion date of September 1, 2020. No set-aside was used.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for a MiSeq System sequencer valued at $95,931.00, with an award date of March 25, 2019 and ultimate completion date of April 5, 2019. Place of performance is San Diego, California. The order is firm fixed price with no set-aside.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $13,785.00 on March 17, 2020, for a MiSeq sequencing system service contract.</p> <p>Performance is located in North Bethesda, Maryland. The order carries a firm fixed price and no set-aside. Ultimate completion was scheduled for April 9, 2021.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. valued at $49,881.00 on September 3, 2015, for a MiSeq Comprehensive Service Agreement (S/N M02211), with ultimate completion on September 29, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $10,901.71 firm fixed price delivery order to Illumina, Inc. for MISEQ REAGENT KITS V3 (INTERNAL AMBIS 2211862) to be delivered to San Diego, California by May 6, 2024. The delivery order was issued under an existing contract vehicle with no set-aside designation. As the sole manufacturer of the MiSeq sequencing platform, Illumina will provide...
- <p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on May 26, 2020, for eight MiSeq Reagent Kit V3 (600 cycle) units with a ceiling value of $12,199.20.</p> <p>Place of performance is San Diego, CA 92122. The order was designated under the National Interest Action Code for Coronavirus COVID-19 response, with an ultimate completion date of September 2, 2020. Pricing was firm fixed price with no set-aside applied.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $14,688.00 on August 14, 2020, for NovaSeq 6000 S4 reagent kits (300 cycles) in support of COVID-19 research. Place of performance is San Diego, California. The order carries firm fixed-price pricing with an ultimate completion date of September 4, 2020.</p>
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for the provision of a MiSeq Reagent Kit V3 (150 cycle). The total ceiling value of the order is $17,121.11 and it has a completion date of July 20, 2016. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $129,931.28 contract is for the purchase of Illumina's MiSeq Reagent Kit V3, a sequencing consumable, without any set-aside designation. Illumina has previously received other prime federal contracts and sub-awards from agencies like the CDC,...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for the procurement of a MiSeq Reagent Kit V3 (600 cycle) with a ceiling value of $38,877.12. There was no set-aside used for this award. Illumina has received numerous prior prime contract awards from federal agencies like NIH, CDC,...
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc., valued at $13,724.10, for a MiSeq Reagent Kit V3 (600-cycle) on September 2, 2020. Place of performance is Bethesda, Maryland. The order was firm fixed-price with an ultimate completion date of October 3, 2020 and was funded under the Coronavirus COVID-19 National Interest Action Code.
Generated 6/2/26, 10:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/3/20 | |
| Not listed | Not listed | $13.7k | 9/1/20 |